JELIKALITE CORP.
SBIR PHASE II: EEG-GUIDED INTELLIGENT TRANSCRANIAL PHOTOBIOMODULATION TO REDUCE SYMPTOMS OF AUTISM -THE BROADER IMPACT/COMMERCIAL POTENTIAL OF THIS SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE II PROJECT INVOLVES DEVELOPING A PERSONALIZED HOME-BASED TREATMENT FOR AUTISTIC CHILDREN. AUTISM SPECTRUM DISORDER IS A COMM
JELIKALITE CORP. operates in national science foundation based in United States.
Profile
JelikaLite is developing a neuromodulation wearable for autistic children to improve communication skills and reduce social anxiety. The device uses transcranial photobiomodulation (tPBM). This noninvasive stimulation technique shines near-infrared light on specific head regions to improve brain function by reducing inflammation, increasing blood flow, and improving functional brain connectivity. JelikeLite is building the first FDA-breakthrough […]
The company sits in the national science foundation segment, where it competes on its core product or service.
The business is associated with United States.
The company is listed at the Phase II stage of development.
It has disclosed roughly $1.1M in funding.
| Sector | National Science Foundation |
|---|---|
| Country | United States |
| Stage | Phase II |
| Total funding | $1,148,025 |
Website: jelikalite.com
Create a free account